GeneDx Holdings (WGS) EBT Margin (2020 - 2026)

GeneDx Holdings (WGS) has reported EBT Margin for 7 consecutive years, with 15.95% the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT Margin fell 2624.0% year-over-year to 15.95% in Q2 2026; TTM through Jun 2026 was 23.39%, a 2381.0% decrease from a year earlier, with the FY2025 full-year figure at 4.94%, up 1229.0% from the prior year.
• EBT Margin was 15.95% for Q2 2026 at GeneDx Holdings, up from 61.04% in the prior quarter.
• Over five years, EBT Margin peaked at 10.29% in Q2 2025 and troughed at 503.13% in Q4 2022.
• A 5-year average of 91.64% and a median of 43.62% in 2023 frame the typical range for EBT Margin.
• Across the five-year window, EBT Margin tumbled 43361 bps in 2022 and soared 45753 bps in 2023, its largest moves.
• Over 5 years, EBT Margin stood at 503.13% in 2022, then jumped by 91 bps to 45.6% in 2023, then surged by 112 bps to 5.66% in 2024, then tumbled by 366 bps to 15.07% in 2025, then fell by 6 bps to 15.95% in 2026.
• The last three EBT Margin figures came in at 15.95% (Q2 2026), 61.04% (Q1 2026), and 15.07% (Q4 2025), per Business Quant data.